Treatment of Lyme Neuroborreliosis with Borrelia-Induced Cerebral Vasculitis
In rare cases, Lyme neuroborreliosis causes cerebral symptoms — including stroke — through Borrelia-induced inflammation of cerebral vessels. This page addresses the management approach specific to this presentation.
Clinical Scenario
Borrelia-induced cerebral vasculitis is a rare complication of Lyme neuroborreliosis. It produces predominantly ischaemic events affecting different areas of the vasculature, with corresponding focal neurological deficits. Recognising Borrelia as the underlying cause of cerebral ischaemia is essential for appropriate treatment.
Treatment Approach (Partial Overview)
Early antibiotic treatment — initiated as soon as possible — forms the foundation of management, following the framework established for late Lyme neuroborreliosis. Adjunctive therapies targeting the vascular inflammatory process may also be considered alongside antibiotic treatment.
The full protocol, including specific antibiotic choices, treatment duration, and adjunctive regimen details, is available via the link below.
References
DOI: 10.3205/000349
- In very rare cases, cerebral symptoms (e.g. strokes) are caused by a Borrelia-induced vasculitis.
- Borrelia-induced cerebral vasculitis: rare, mainly ischemic events in different areas of the bloodstream with corresponding neurological symptoms.
- Cerebral vasculitis resulting from Lyme borreliosis should be treated with antibiotics in accordance with the recommendations for "late" Lyme neuroborreliosis.
- Case reports, case series and narrative reviews have reported that early antibiotic treatment with ceftriaxone and/or doxycycline has very good outcomes.
- Analogous to the recommendations for cerebral vasculitis of another aetiology (DGN S1 guideline on cerebral vasculitis, AWMF Register No. 030-085), the additional administration of steroids and/or 100 mg/d of ASA can be considered for cerebral vasculitis resulting from Lyme borreliosis.
View source ↗